Viral Load Assessment
Viral Load Assessment - Related Videos
03:40
Plaque Assay–Based Quantification of Viral Load in an Infected Mouse Tissue Sample
0 Views •
2026
Source: Morales Vasquez, D., et al. Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2. J. Vis. Exp. (2021)This video demonstrates the protocol for carrying out plaque assay–based viral titration for quantifying infectious virus levels in tissue sample collected from a virus–infected mouse model.
02:27
Measuring Hepatitis C Viral Load Using Quantitative Reverse Transcription Polymerase Chain Reaction
0 Views •
2026
Source: Ren, S., et al. A Protocol for Analyzing Hepatitis C Virus Replication. J. Vis. Exp. (2014).This video demonstrates the procedure for quantifying Hepatitis C viral RNA using quantitative reverse transcription PCR to measure viral load in infected cell cultures.
03:41
Assessing the Effectiveness of an Antiviral Test Compound through a Viral Inactivation Assay
0 Views •
2025
This video demonstrates the viral inactivation assay, showcasing the evaluation of the impact of antiviral agents on viral particles.
02:57
Assessing Antiviral Cytokine Production in Response to Viral Infection
0 Views •
2026
Source: Zhang, J., et al. Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production. J. Vis. Exp. (2014)This video demonstrates the process of infecting murine fibroblast cells with herpesvirus and monitoring the resulting antiviral cytokine release and gene expression. It outlines key steps, including viral infection, media collection for cytokine quantification, and cell harvesting for gene expression analysis.
13:58
Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
0 Views •
Cited by 10 •
2011
Quantifying levels of HIV-1 RNA in plasma and sequencing single HIV-1 genomes from individuals with viral loads below the limit of detection (50-75 copies/ml) is difficult. Here we describe how to extract and quantify plasma viral RNA using a real time PCR assay that reliably measures HIV-1 RNA down to 0.3 copies/ml and how to amplify viral genomes by single genome sequencing, from samples with very low viral loads.
FAQs
Real-time PCR generates a fluorescence signal that can be related to the amount of amplified viral nucleic acid. Calibration standards provide the reference needed to translate that signal into an estimate of viral copies or genome equivalents. This relationship makes measurements comparable within the assay and supports quantitative interpretation rather than a simple present-or-absent result.
Extraction isolates viral nucleic acids from blood or another biological specimen so the target material can enter the quantification assay. Because the measurement depends on this prepared material, consistent extraction helps the signal represent the original sample more reliably. This consistency becomes especially important when comparing specimens or monitoring changes during infection.
Repeated measurements allow investigators to follow infection status and disease activity as they change over time. This longitudinal view can show whether viral levels move in a pattern associated with antiviral treatment or disease progression, whereas an isolated value provides only one time point. Such trends help evaluate responses and compare trajectories in clinical or research studies.
A typical workflow begins with collecting blood or another biological specimen, extracting viral nucleic acids, and applying real-time PCR. Fluorescence is interpreted against calibration standards to estimate viral copies or genome equivalents. Assay controls and consistent reporting are then used to support meaningful interpretation and comparisons among measurements collected during a study.
Comparable results depend on accurate sampling, appropriate assay controls, and consistent reporting. Variability in specimen collection or in how results are documented can complicate comparisons, even when the underlying biological state is similar. Maintaining the same practices across time points therefore strengthens interpretation of treatment response, disease progression, and other longitudinal patterns.
In biology, measurements can connect the amount of virus in a specimen with questions about disease progression, treatment response, transmission, and host-pathogen interactions. Researchers can use the resulting quantitative data to compare infection patterns over time or across studies. This makes viral load a useful measurement for linking molecular evidence of infection with broader biological processes.